Patents by Inventor Martin Karl Russel Burnham

Martin Karl Russel Burnham has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • M protein
    Patent number: 5882896
    Abstract: The invention provides M Protein polypeptides and DNA (RNA) encoding M Protein polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing M Protein polypeptides to screen for antibacterial compounds.
    Type: Grant
    Filed: September 15, 1997
    Date of Patent: March 16, 1999
    Assignees: Smithkline Beecham Corporation, Smithkline Beecham, p.l.c.
    Inventors: Martin Karl Russel Burnham, Stephen Dudley Holmes
  • Saliva binding protein
    Patent number: 5882871
    Abstract: The invention provides Saliva Binding Protein polypeptides and DNA (RNA) encoding Saliva Binding Protein polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing Saliva Binding Protein polypeptides to screen for antibacterial compounds.
    Type: Grant
    Filed: September 12, 1997
    Date of Patent: March 16, 1999
    Assignees: SmithKline Beecham Corporation, SmithKline Beecham p.l.c.
    Inventor: Martin Karl Russel Burnham
  • Aminopeptidase
    Patent number: 5866370
    Abstract: The invention provides aminopeptidase polypeptides and DNA (RNA) encoding aminopeptidase polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing aminopeptidase polypeptides to screen for antibacterial compounds.
    Type: Grant
    Filed: November 5, 1997
    Date of Patent: February 2, 1999
    Assignee: SmithKline Beecham Corporation
    Inventors: Sanjoy Biswas, Martin Karl Russel Burnham, Michael Arthur Lonetto, Patrick Vernon Warren, Richard Lloyd Warren
  • Glucose kinase from streptococcus pneumoniae
    Patent number: 5840560
    Abstract: The invention provides Glucose Kinase polypeptides and DNA (RNA) encoding Glucose Kinase polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing Glucose Kinase polypeptides to screen for antibacterial compounds.
    Type: Grant
    Filed: July 17, 1997
    Date of Patent: November 24, 1998
    Assignee: SmithKline Beecham Corporation
    Inventors: Michael Terence Black, John Edward Hodgson, David Justin Charles Knowles, Michael Arthur Lonetto, Richard O. Nicholas, Robert King Stodola, Martin Karl Russel Burnham